Categories: News

2024 Resident of Distinction Award(TM) Recipients Recognized at Maui Derm Hawaii

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Beiersdorf Sponsors Top Dermatology Residents to Attend the 2024 Maui Derm Hawaii Conference

WAILEA, HI / ACCESSWIRE / February 1, 2024 / DermMentors™ announced today that as part of the 13th Annual dermMentors™ Resident of Distinction Award™, Beiersdorf Inc. sponsored five top dermatology residents to attend the 2024 Maui Derm Hawaii conference, held in Wailea Beach, Maui, Hawaii, from January 22-26, 2024.

Dermatology Residents Recognized at Maui Derm 2024
2024 Awardees (From left) Dawn Queen, MD, Seher Banu Farabi Atak, MD, Maria Buethe, MD, PhD, Chloe Fernandez, DO, and Jason Klein, MD, PhD.

As selected by the dermMentors™ Faculty, the resident awardees – Maria Buethe, MD, PhD, of The University of California-San Diego/Rady Children’s Hospital, Seher Banu Farabi Atak, MD, of New York Medical College/Metropolitan Hospital Center, Chloe Fernandez, DO, of Kansas City University/Orlando Dermatology, Jason Klein, MD, PhD, of the University of Texas Southwestern, and Dawn Queen, MD, of Columbia University – attended the scientific sessions as well as networking and mentorship events with thought leaders in dermatology. The Residents presented their research during the Maui Derm “Talk Story” sessions on January 22-24.

George Martin, MD, Program Director for Maui Derm, presides over the Resident of Distinction Award™ as Medical Director, and the 2024 dermMentors™ Faculty were world-renowned dermatologists Hilary Baldwin, MD, of Rutgers University, Raj Chovatiya, MD, PhD, of Northwestern University, Sheila Friedlander, MD, of Scripps Health, Ted Rosen, MD, of the Baylor College of Medicine, and Linda Stein Gold, MD, of the Henry Ford Health System.

###

Established in 2011, dermMentors.org and the dermMentors™ Resident of Distinction Award™ program are sponsored by Beiersdorf Inc., the makers of Eucerin® and Aquaphor®, and administered by Evince Communications, LLC. Now in its 13th year, the dermMentors™ Resident of Distinction Award™ recognizes top residents in dermatology for their standout research and dedication to their field, while providing them with insights from respected thought leaders and facilitating and fostering relationships between residents and mentors in dermatology.

For more information, visit www.dermMentors.org, contact Evince Communications at (203) 354-6953, or email info@dermmentors.org.

Contact Information

Daniel Romanowitz
Writer
dromanowitz@evincecom.com
(203) 354-6953

SOURCE: Beiersdorf, Inc.

View the original press release on newswire.com.

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

6 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

6 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

9 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

9 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

9 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

9 hours ago